Published in Schizophr Bull on January 06, 2010
Increased intra-individual variability of cognitive processing in subjects at risk mental state and schizophrenia patients. PLoS One (2013) 1.44
Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification. Schizophr Bull (2011) 1.36
Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. Am J Psychiatry (2011) 1.28
A comprehensive review of auditory verbal hallucinations: lifetime prevalence, correlates and mechanisms in healthy and clinical individuals. Front Hum Neurosci (2013) 1.20
Neurocognition in the extended psychosis phenotype: performance of a community sample of adolescents with psychotic symptoms on the MATRICS neurocognitive battery. Schizophr Bull (2012) 1.05
Early and broadly defined psychosis risk mental states. Schizophr Res (2010) 1.01
A stratified model for psychosis prediction in clinical practice. Schizophr Bull (2014) 0.97
Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state. PLoS One (2013) 0.95
Insular volume abnormalities associated with different transition probabilities to psychosis. Psychol Med (2011) 0.89
Clinical and cognitive risk factors for psychotic symptoms in 22q11.2 deletion syndrome: a transversal and longitudinal approach. Eur Child Adolesc Psychiatry (2013) 0.87
Mismatch and lexical retrieval gestures are associated with visual information processing, verbal production, and symptomatology in youth at high risk for psychosis. Schizophr Res (2014) 0.86
Neurocognitive functioning in schizophrenia and during the early phases of psychosis: targeting cognitive remediation interventions. Biomed Res Int (2013) 0.85
A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis. Eur Arch Psychiatry Clin Neurosci (2011) 0.85
Revisiting the Basic Symptom Concept: Toward Translating Risk Symptoms for Psychosis into Neurobiological Targets. Front Psychiatry (2016) 0.84
Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry (2016) 0.82
Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at Adulthood. PLoS One (2015) 0.79
Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients. Eur Arch Psychiatry Clin Neurosci (2016) 0.78
EEG-Informed fMRI Reveals a Disturbed Gamma-Band-Specific Network in Subjects at High Risk for Psychosis. Schizophr Bull (2015) 0.77
Neuropsychological Impairment in Prodromal, First-Episode, and Chronic Psychosis: Assessing RBANS Performance. PLoS One (2015) 0.76
A developmental look at the attentional system in the at risk and first episode of psychosis: age related changes in attention along the psychosis spectrum. Cogn Neuropsychiatry (2012) 0.76
Various neurocognitive deficits and conversion risk in individuals at clinical high risk for psychosis. Early Interv Psychiatry (2015) 0.76
Different vulnerability indicators for psychosis and their neuropsychological characteristics in the Northern Finland 1986 Birth Cohort. J Clin Exp Neuropsychol (2011) 0.76
Reduced P300 amplitude during retrieval on a spatial working memory task in a community sample of adolescents who report psychotic symptoms. BMC Psychiatry (2013) 0.75
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40
What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry (1996) 11.03
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry (2008) 9.54
Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry (1987) 8.81
Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology (1998) 8.73
Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry (2001) 5.35
The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain (1999) 5.13
Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet (2003) 4.91
Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry (2007) 4.44
The relation of the trail making test to organic brain damage. J Consult Psychol (1955) 4.33
Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res (2003) 3.86
Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry (1999) 3.69
The primacy of cognition in schizophrenia. Am Psychol (2005) 3.64
Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry (2006) 3.62
Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man. Neuropsychologia (1982) 3.56
Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology (2009) 3.27
Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect? Arch Gen Psychiatry (2007) 3.26
The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull (1996) 3.07
Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry (2001) 2.95
Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry (2000) 2.93
The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull (2003) 2.67
The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res (1988) 2.61
Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry (1998) 2.53
Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry (2005) 2.43
Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry (2009) 2.17
Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage (2005) 2.09
Associations between premorbid intellectual performance, early-life exposures and early-onset schizophrenia. Cohort study. Br J Psychiatry (2002) 2.05
Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res (2009) 1.98
School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study. Arch Gen Psychiatry (1999) 1.97
Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry (2005) 1.84
Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry (2006) 1.81
Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull (2000) 1.78
Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am J Psychiatry (2000) 1.77
Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms. Neuropsychol Rev (2003) 1.71
Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res (2006) 1.67
Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'. Schizophr Res (2004) 1.65
A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. Am J Psychiatry (2003) 1.63
Epidemiology of schizophrenia. Can J Psychiatry (1997) 1.61
Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophr Res (2003) 1.60
Cognitive and behavioral precursors of schizophrenia. Dev Psychopathol (1999) 1.60
Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry (2005) 1.55
Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr Bull (2006) 1.54
Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol Med (2000) 1.52
Cognitive functioning in the schizophrenia prodrome. Schizophr Bull (2007) 1.44
Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophr Res (2004) 1.42
Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Am J Psychiatry (1999) 1.41
Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res (2006) 1.38
Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis. Schizophr Res (2007) 1.38
Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci (2004) 1.34
Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol. Am J Psychiatry (2007) 1.32
Spatial working memory ability is a marker of risk-for-psychosis. Psychol Med (2003) 1.32
Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophr Res (2005) 1.32
Neurocognitive deficits in the (putative) prodrome and first episode of psychosis. Schizophr Res (2007) 1.29
Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophr Res (2003) 1.26
Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Arch Gen Psychiatry (1994) 1.20
Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am J Psychiatry (1999) 1.19
Correlates of cognitive deficits in first episode schizophrenia. Schizophr Res (2004) 1.15
Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. Biol Psychiatry (2008) 1.14
Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic. Br J Psychiatry Suppl (2002) 1.13
Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia. J Clin Exp Neuropsychol (2006) 1.10
Neurocognitive profile in adolescents with early-onset schizophrenia: clinical correlates. Biol Psychiatry (2005) 1.08
The persistence of developmental markers in childhood and adolescence and risk for schizophrenic psychoses in adult life. A 34-year follow-up of the Northern Finland 1966 birth cohort. Schizophr Res (2004) 1.05
Transition to schizophrenia and related disorders: toward a taxonomy of risk. Schizophr Bull (2003) 1.05
Infant motor development and adult cognitive functions in schizophrenia. Schizophr Res (2005) 1.03
Sustained attention in young people at high risk of psychosis does not predict transition to psychosis. Schizophr Res (2005) 1.02
Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes. Br J Psychiatry (2009) 1.02
Neuropsychological performance over time in people at high risk of developing schizophrenia and controls. Biol Psychiatry (2006) 1.00
Neuropsychological deficits in individuals with an at risk mental state for psychosis - working memory as a potential trait marker. Schizophr Res (2007) 0.98
Neuropsychological performance at the age of 13 years and adult schizophreniform disorder: prospective birth cohort study. Br J Psychiatry (2006) 0.98
Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state. Psychol Med (2008) 0.96
Auditory P300 in individuals clinically at risk for psychosis. Int J Psychophysiol (2008) 0.94
[Schizophrenia. Clinical course and social psychiatric long term examinations of schizophrenic patients hospitalized in Bonn from 1945-1959]. Monogr Gesamtgeb Psychiatr Psychiatry Ser (1979) 0.93
Cognitive and behavioural functioning in men with schizophrenia both before and shortly after first admission to hospital. Cross-sectional analysis. Br J Psychiatry (2000) 0.91
Neurodevelopment and the transition from schizophrenia prodrome to schizophrenia: research imperatives. Biol Psychiatry (2008) 0.89
Neuropsychology, genetic liability, and psychotic symptoms in those at high risk of schizophrenia. J Abnorm Psychol (2003) 0.87
Neuropsychological correlates of symptom profiles in first episode schizophrenia. Schizophr Res (2004) 0.86
Specificity of developmental precursors to schizophrenia and affective disorders. Schizophr Res (1999) 0.86
Fine motor function and neuropsychological deficits in individuals at risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci (2005) 0.85
Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms. Psychiatry Res (2005) 0.85
Is executive impairment associated with schizophrenic syndromes? A meta-analysis. Psychol Med (2008) 0.84
First- and second-generation antipsychotic medication and cognitive processing in schizophrenia. Curr Psychiatry Rep (2005) 0.84
The Brief Motor Scale (BMS) for the assessment of motor soft signs in schizophrenic psychoses and other psychiatric disorders. Psychiatry Res (2006) 0.84
Neurodevelopmental models of schizophrenia: pathophysiologic synthesis and directions for intervention research. Psychopharmacol Bull (2001) 0.79
When does cognitive decline occur in the period prior to the first episode of schizophrenia? Psychiatry (Edgmont) (2009) 0.79
Neurobehavioral deficits in young adult offspring with heightened risk for psychosis who developed schizophrenia-spectrum disorder. Schizophr Res (2007) 0.77
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet (2008) 10.52
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet (2008) 6.24
A 3.9-centimorgan-resolution human single-nucleotide polymorphism linkage map and screening set. Am J Hum Genet (2003) 5.34
Sponge-associated microorganisms: evolution, ecology, and biotechnological potential. Microbiol Mol Biol Rev (2007) 5.24
A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet (2009) 5.01
Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet (2008) 4.78
WPA guidance on how to combat stigmatization of psychiatry and psychiatrists. World Psychiatry (2010) 4.26
Molecular evidence for a uniform microbial community in sponges from different oceans. Appl Environ Microbiol (2002) 4.24
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
Deciphering the evolution and metabolism of an anammox bacterium from a community genome. Nature (2006) 4.06
probeBase--an online resource for rRNA-targeted oligonucleotide probes: new features 2007. Nucleic Acids Res (2006) 3.98
Microbial diversity and the genetic nature of microbial species. Nat Rev Microbiol (2008) 3.89
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry (2010) 3.88
Identifying depression in primary care: a comparison of different methods in a prospective cohort study. BMJ (2003) 3.78
A moderately thermophilic ammonia-oxidizing crenarchaeote from a hot spring. Proc Natl Acad Sci U S A (2008) 3.76
The microbial community composition of a nitrifying-denitrifying activated sludge from an industrial sewage treatment plant analyzed by the full-cycle rRNA approach. Syst Appl Microbiol (2002) 3.65
Illuminating the evolutionary history of chlamydiae. Science (2004) 3.39
Oligonucleotide microarray for 16S rRNA gene-based detection of all recognized lineages of sulfate-reducing prokaryotes in the environment. Appl Environ Microbiol (2002) 3.26
Nitrososphaera viennensis, an ammonia oxidizing archaeon from soil. Proc Natl Acad Sci U S A (2011) 3.25
Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet (2005) 3.24
probeBase: an online resource for rRNA-targeted oligonucleotide probes. Nucleic Acids Res (2003) 3.23
Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. J Neurosci (2010) 3.12
Genome-wide association study of alcohol dependence. Arch Gen Psychiatry (2009) 3.08
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophr Res (2013) 3.01
Selection of genetic markers for association analyses, using linkage disequilibrium and haplotypes. Am J Hum Genet (2003) 2.94
daime, a novel image analysis program for microbial ecology and biofilm research. Environ Microbiol (2006) 2.88
Distinct gene set in two different lineages of ammonia-oxidizing archaea supports the phylum Thaumarchaeota. Trends Microbiol (2010) 2.84
Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression. Br J Psychiatry (2005) 2.84
Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data. Int J Neuropsychopharmacol (2010) 2.74
The diagnosis and treatment of generalized anxiety disorder. Dtsch Arztebl Int (2013) 2.73
Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet (2011) 2.71
Deep sequencing reveals exceptional diversity and modes of transmission for bacterial sponge symbionts. Environ Microbiol (2009) 2.68
Oligonucleotide microarray for identification of Enterococcus species. FEMS Microbiol Lett (2005) 2.67
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry (2008) 2.64
Deep brain stimulation for psychiatric disorders. Dtsch Arztebl Int (2010) 2.60
Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophr Bull (2008) 2.59
Amoebae as training grounds for intracellular bacterial pathogens. Appl Environ Microbiol (2005) 2.59
Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year. Clin Neurol Neurosurg (2009) 2.57
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57
Descending necrotizing mediastinitis: contemporary trends in etiology, diagnosis, management, and outcome. Ann Surg (2010) 2.57
Barcoded primers used in multiplex amplicon pyrosequencing bias amplification. Appl Environ Microbiol (2011) 2.52
Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet (2010) 2.46
Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res (2008) 2.45
An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am J Psychiatry (2014) 2.43
Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry (2010) 2.41
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. World J Biol Psychiatry (2007) 2.40
A standardized boundary element method volume conductor model. Clin Neurophysiol (2002) 2.30
A Nitrospira metagenome illuminates the physiology and evolution of globally important nitrite-oxidizing bacteria. Proc Natl Acad Sci U S A (2010) 2.25
Current state and perspectives of fungal DNA barcoding and rapid identification procedures. Appl Microbiol Biotechnol (2010) 2.24
New insights into metabolic properties of marine bacteria encoding proteorhodopsins. PLoS Biol (2005) 2.23
Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry (2009) 2.17
Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry (2002) 2.15
The Thaumarchaeota: an emerging view of their phylogeny and ecophysiology. Curr Opin Microbiol (2011) 2.14
Discovery of the novel candidate phylum "Poribacteria" in marine sponges. Appl Environ Microbiol (2004) 2.13
Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry (2004) 2.12
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. J Clin Psychiatry (2009) 2.09
Progressive cognitive dysfunction in spinocerebellar ataxia type 3. Mov Disord (2013) 2.09
The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat (2003) 2.08
Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry (2007) 2.05
Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry (2010) 2.04
Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment. Neuroimage (2007) 2.03
Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. Brain (2005) 2.03
The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron (2011) 2.02
amoA-based consensus phylogeny of ammonia-oxidizing archaea and deep sequencing of amoA genes from soils of four different geographic regions. Environ Microbiol (2011) 2.02
Who eats what, where and when? Isotope-labelling experiments are coming of age. ISME J (2007) 1.99
Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet (2002) 1.99
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia. World J Biol Psychiatry (2005) 1.98
Zero-valent sulphur is a key intermediate in marine methane oxidation. Nature (2012) 1.97
Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment. Neurology (2012) 1.94
Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness. Am J Psychiatry (2011) 1.94
Outcome in psychogenic nonepileptic seizures: 1 to 10-year follow-up in 164 patients. Ann Neurol (2003) 1.93
Reduction in the incidence of influenza A but not influenza B associated with use of hand sanitizer and cough hygiene in schools: a randomized controlled trial. Pediatr Infect Dis J (2011) 1.87
Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies. Patient Educ Couns (2003) 1.85
probeCheck--a central resource for evaluating oligonucleotide probe coverage and specificity. Environ Microbiol (2008) 1.85
Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection. Neuroimage (2004) 1.84
Prefrontal transcranial direct current stimulation changes connectivity of resting-state networks during fMRI. J Neurosci (2011) 1.81
Do schizoaffective disorders exist at all? Acta Psychiatr Scand (2006) 1.79
Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies. J Clin Microbiol (2004) 1.76
Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. Arch Neurol (2005) 1.75
Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism. Arch Gen Psychiatry (2008) 1.75